243 related articles for article (PubMed ID: 35211255)
1. Recent advances of cancer chemodynamic therapy based on Fenton/Fenton-like chemistry.
Cao C; Wang X; Yang N; Song X; Dong X
Chem Sci; 2022 Jan; 13(4):863-889. PubMed ID: 35211255
[TBL] [Abstract][Full Text] [Related]
2. Strategies for enhancing cancer chemodynamic therapy performance.
Jana D; Zhao Y
Exploration (Beijing); 2022 Apr; 2(2):20210238. PubMed ID: 37323881
[TBL] [Abstract][Full Text] [Related]
3. Harnessing inorganic nanomaterials for chemodynamic cancer therapy.
Mohammed DF; Madlool HA; Faris M; Shalan BH; Hasan HH; Azeez NF; Abbas FH
Nanomedicine (Lond); 2022 Oct; 17(24):1891-1906. PubMed ID: 36647807
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in multifunctional nanomaterials for photothermal-enhanced Fenton-based chemodynamic tumor therapy.
Manivasagan P; Joe A; Han HW; Thambi T; Selvaraj M; Chidambaram K; Kim J; Jang ES
Mater Today Bio; 2022 Jan; 13():100197. PubMed ID: 35036895
[TBL] [Abstract][Full Text] [Related]
5. Strategies to engineer various nanocarrier-based hybrid catalysts for enhanced chemodynamic cancer therapy.
Hao JN; Ge K; Chen G; Dai B; Li Y
Chem Soc Rev; 2023 Nov; 52(22):7707-7736. PubMed ID: 37874584
[TBL] [Abstract][Full Text] [Related]
6. Research Progress on Improving the Efficiency of CDT by Exacerbating Tumor Acidification.
Chen W; Liu J; Zheng C; Bai Q; Gao Q; Zhang Y; Dong K; Lu T
Int J Nanomedicine; 2022; 17():2611-2628. PubMed ID: 35712639
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
8. Chemodynamic Therapy via Fenton and Fenton-Like Nanomaterials: Strategies and Recent Advances.
Jia C; Guo Y; Wu FG
Small; 2022 Feb; 18(6):e2103868. PubMed ID: 34729913
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Assessment of Enhanced Chemodynamic Therapy by an FeMnO
Dirersa WB; Kan TC; Getachew G; Wibrianto A; Ochirbat S; Rasal A; Chang J; Chang JY
ACS Appl Mater Interfaces; 2023 Dec; 15(48):55258-55275. PubMed ID: 38013418
[TBL] [Abstract][Full Text] [Related]
10. Nanosystems for chemodynamic based combination therapy: Strategies and recent advances.
Li M; Zhang W; Xu X; Liu G; Dong M; Sun K; Zhang P
Front Pharmacol; 2022; 13():1065438. PubMed ID: 36386143
[TBL] [Abstract][Full Text] [Related]
11. The Application of Biomedicine in Chemodynamic Therapy: From Material Design to Improved Strategies.
Cheng B; Li D; Li C; Zhuang Z; Wang P; Liu G
Bioengineering (Basel); 2023 Aug; 10(8):. PubMed ID: 37627810
[TBL] [Abstract][Full Text] [Related]
12. Emerging Chemodynamic Nanotherapeutics for Cancer Treatment.
Sun D; Sun X; Zhang X; Wu J; Shi X; Sun J; Luo C; He Z; Zhang S
Adv Healthc Mater; 2024 May; ():e2400809. PubMed ID: 38752756
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-loaded hydrogen peroxide self-providing copper nanodots for combination of chemotherapy and acid-induced chemodynamic therapy against breast cancer.
Li JX; Zhang LM; Liu CC; Wu QN; Li SP; Lei XP; Huang YG; Feng GN; Yu XY; Sun XQ; Guo ZM; Fu JJ
J Colloid Interface Sci; 2021 Jul; 593():323-334. PubMed ID: 33744541
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions.
Gao H; Cao Z; Liu H; Chen L; Bai Y; Wu Q; Yu X; Wei W; Wang M
Theranostics; 2023; 13(6):1974-2014. PubMed ID: 37064867
[TBL] [Abstract][Full Text] [Related]
15. Nanocatalyst-Mediated Chemodynamic Tumor Therapy.
Zhang L; Li CX; Wan SS; Zhang XZ
Adv Healthc Mater; 2022 Jan; 11(2):e2101971. PubMed ID: 34751505
[TBL] [Abstract][Full Text] [Related]
16. Low-intensity focused ultrasound-augmented Cascade chemodynamic therapy via boosting ROS generation.
Deng L; Liu M; Sheng D; Luo Y; Wang D; Yu X; Wang Z; Ran H; Li P
Biomaterials; 2021 Apr; 271():120710. PubMed ID: 33610047
[TBL] [Abstract][Full Text] [Related]
17. GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo-Chemodynamic Combination Therapy.
Zhu P; Luo W; Qian J; Meng C; Shan W; Xu Z; Zhang W; Liu X; Ling Y
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641443
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in nanoscale metal-organic frameworks for cancer chemodynamic therapy.
Ji M; Liu H; Gou J; Yin T; He H; Zhang Y; Tang X
Nanoscale; 2023 May; 15(20):8948-8971. PubMed ID: 37129051
[TBL] [Abstract][Full Text] [Related]
19. Nanotrains of DNA Copper Nanoclusters That Triggered a Cascade Fenton-Like Reaction and Glutathione Depletion to Doubly Enhance Chemodynamic Therapy.
Li Q; Wang F; Shi L; Tang Q; Li B; Wang X; Jin Y
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37280-37290. PubMed ID: 35968633
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional nanosystems sequentially regulating intratumor Fenton chemistry by remodeling the tumor microenvironment to reinforce chemodynamic therapy.
Dong K; Chen W; Zhao Z; Zhang Y; Wang P; Wang K; Xing J; Lu T; Dong Y
Biomater Adv; 2022 Jul; 138():212957. PubMed ID: 35913243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
